Literature DB >> 17699659

Enhanced nicotinic receptor function and drug abuse vulnerability.

Zara M Fagen1, Robert Mitchum, Paul Vezina, Daniel S McGehee.   

Abstract

In animals and humans, vulnerability to drug abuse varies among individuals. Animals that display high activity levels in a novel environment are more likely to self-administer psychostimulant drugs, including nicotine, cocaine, amphetamine, and morphine. Recent reports from behavioral studies indicate that nicotinic acetylcholine receptor (nAChR) activity contributes to the rewarding effects of several different addictive drugs. Thus, we hypothesized that differences in nAChR activity may contribute to the predisposition to drug self-administration. After screening of adult rats (>60 d postnatal) for the behavioral response to a novel environment, electrophysiological measures of nAChR function were conducted in brain slices that included the mesoaccumbens dopamine neurons of the ventral tegmental area (VTA). We found a positive correlation between the response to novelty and nAChR function in each assay conducted, including nAChR modulation of glutamatergic and GABAergic synaptic inputs to VTA dopamine neurons, as well as somatic nAChR responses of VTA neurons. The response to novelty and sensitivity to addictive drugs are positively correlated with the hormonal response to stress. Consistent with this observation, we found enhanced nAChR responses in vitro after a 48 h corticosterone treatment and in vivo after 48 h of repeated stress. Each of these effects was inhibited by RU486 (11beta-[p-(dimethylamino)phenyl]-17beta-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one) pretreatment, suggesting a steroid hormone receptor-dependent process. These findings suggest that differences in nAChR function within the mesoaccumbens dopamine system may contribute to individual differences in drug abuse vulnerability and that these are likely attributable to differences in stress hormone levels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17699659      PMCID: PMC6672186          DOI: 10.1523/JNEUROSCI.2017-06.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  18 in total

1.  Gates and filters: unveiling the physiological roles of nicotinic acetylcholine receptors in dopaminergic transmission.

Authors:  S Wonnacott
Journal:  Br J Pharmacol       Date:  2008-02-04       Impact factor: 8.739

2.  Childhood adversity increases risk for nicotine dependence and interacts with α5 nicotinic acetylcholine receptor genotype specifically in males.

Authors:  Pingxing Xie; Henry R Kranzler; Huiping Zhang; David Oslin; Raymond F Anton; Lindsay A Farrer; Joel Gelernter
Journal:  Neuropsychopharmacology       Date:  2011-10-19       Impact factor: 7.853

3.  α6β2 subunit containing nicotinic acetylcholine receptors exert opposing actions on rapid dopamine signaling in the nucleus accumbens of rats with high-versus low-response to novelty.

Authors:  Cody A Siciliano; J Michael McIntosh; Sara R Jones; Mark J Ferris
Journal:  Neuropharmacology       Date:  2017-06-27       Impact factor: 5.250

4.  Locomotor and stress responses to nicotine differ in adolescent and adult rats.

Authors:  Junran Cao; James D Belluzzi; Sandra E Loughlin; Jasmin M Dao; Yiling Chen; Frances M Leslie
Journal:  Pharmacol Biochem Behav       Date:  2010-04-25       Impact factor: 3.533

Review 5.  Age matters.

Authors:  James Edgar McCutcheon; Michela Marinelli
Journal:  Eur J Neurosci       Date:  2009-03       Impact factor: 3.386

6.  Stress-induced changes in nucleus accumbens glutamate synaptic plasticity.

Authors:  Matthew R Campioni; Ming Xu; Daniel S McGehee
Journal:  J Neurophysiol       Date:  2009-04-08       Impact factor: 2.714

7.  Long-term nicotine treatment differentially regulates striatal alpha6alpha4beta2* and alpha6(nonalpha4)beta2* nAChR expression and function.

Authors:  Xiomara A Perez; Tanuja Bordia; J Michael McIntosh; Sharon R Grady; Maryka Quik
Journal:  Mol Pharmacol       Date:  2008-06-26       Impact factor: 4.436

8.  Intermittent nicotine exposure upregulates nAChRs in VTA dopamine neurons and sensitises locomotor responding to the drug.

Authors:  Lorinda K Baker; Danyan Mao; Henry Chi; Anitha P Govind; Yolanda F Vallejo; Michael Iacoviello; Stacy Herrera; James J Cortright; William N Green; Daniel S McGehee; Paul Vezina
Journal:  Eur J Neurosci       Date:  2013-01-21       Impact factor: 3.386

9.  Understanding counselors' implementation of tobacco cessation services with patients.

Authors:  Lillian T Eby; Tanja C Laschober; Jessica L Muilenburg
Journal:  J Subst Abuse Treat       Date:  2014-06-28

10.  Adenylyl cyclase type 5 contributes to corticostriatal plasticity and striatum-dependent learning.

Authors:  Mazen A Kheirbek; Jon P Britt; Jeff A Beeler; Yoshihiro Ishikawa; Daniel S McGehee; Xiaoxi Zhuang
Journal:  J Neurosci       Date:  2009-09-30       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.